Us Dept Of Health & Human Services Clinic/Center - Public Health, Federal Medicare: Not Enrolled in Medicare Practice Location: 100 Lake Traverse Dr, Sisseton, SD 57262 Phone: 605-698-7606 |
Coteau Des Prairies Health Care System Rosholt Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 Orchard Drive, Sisseton, SD 57262 Phone: 605-698-7647 Fax: 605-698-4626 |
Sisse-whapeton Oyate Health Care Center And Sisseton Indian Health Ser Clinic/Center Medicare: Medicare Enrolled Practice Location: 100 Lake Traverse Drive, Sisseton, SD 57262 Phone: 605-698-7606 Fax: 605-742-3882 |
Sisseton Wahpeton Health Care Center Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 100 Lake Traverse Dr, Sisseton, SD 57262 Phone: 605-698-7606 |
Coteau Des Prairies Health Care System Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 Orchard Dr, Sisseton, SD 57262 Phone: 605-698-7681 Fax: 605-698-3493 |
Coteau Des Prairies Health Care System Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 205 Orchard Drive, Sisseton, SD 57262 Phone: 605-698-7681 Fax: 605-698-3493 |
Thielen Chiropractic Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1920 South Dakota Hwy 10, Sisseton, SD 57262 Phone: 605-698-3522 Fax: 605-698-4465 |
News Archive
A new study by the Wildlife Conservation Society's Animal & Human Health for the Environment And Development (AHEAD) Program, World Wildlife Fund (WWF), and regional partners finds that a new approach to beef production in southern Africa could positively transform livelihoods for farmers and pastoralists, while helping to secure a future for wildlife and wildlife-based tourism opportunities.
Bronchodilator responsiveness, nasal inflammation and allergy were among the most significant baseline features that distinguished hard-to-control asthma in inner-city children and adolescents.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that U.S. and European (France, Germany, Italy, Spain and U.K.) sales of Roche/Biogen Idec's Rituxan/MabThera, Bristol-Myers Squibb/Merck's Erbitux and Roche's Herceptin will peak at almost $16 billion in 2014, before falling to roughly $10 billion in 2018.
Many couples who have trouble conceiving a child have turned to a process known as in vitro fertilization.
› Verified 4 days ago